Ciphergen Announces Publication Of Data Describing Application For Evaluating Patients With Blood Disorder

... Ciphergen Biosystems, Inc. (Nasdaq: CIPH) today announced that its clinical development partner Ohio State University published an article describing the use of Surface Enhanced Laser Desorption/Ionization Time of Flight (SELDI-TOF) mass spectrometry for the diagnosis and clinical evaluation of thrombotic thrombocytopenic purpura (TTP), a hematologic disease. [click link for full article] ...